Literature DB >> 32810619

The signaling pathways and targets of traditional Chinese medicine and natural medicine in triple-negative breast cancer.

Zimei Yang1, Qiuhua Zhang2, Linghong Yu3, Jiayan Zhu4, Yi Cao5, Xiufei Gao6.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Triple-negative breast cancer (TNBC) has a poorer prognosis than other subtypes due to its strong invasion and higher risk of distant metastasis. Traditional Chinese medicine (TCM) and natural medicine have the unique advantages of multitargets and small side-effects and may be used as long-term complementary and alternative therapies. AIM OF THE REVIEW: The present article summarizes the classical signaling pathways and potential targets by the action of TCM and natural medicine (including extracts, active constituents and formulas) on TNBC and provides evidence for its clinical efficacy.
METHODS: The literature information was acquired from the scientific databases PubMed, Web of Science and CNKI from January 2010 to June 2020, and it was designed to elucidate the internal mechanism and role of TCM and natural medicine in the treatment of TNBC. The search key words included "Triple negative breast cancer" or "triple negative breast carcinoma", "TNBC" and "traditional Chinese medicine" or "Chinese herbal medicine", "medicinal plant", "natural plant", and "herb".
RESULTS: We described the antitumor activity of TCM and natural medicine in TNBC based on different signaling pathways. Plant medicine and herbal formulas regulated the related gene and protein expression via pathways such as PI3K/AKT/mTOR, MAPK and Wnt/β-catenin, which inhibit the growth, proliferation, migration, invasion and metastasis of TNBC cells.
CONCLUSION: The inhibitory effect of TCM and natural medicine on tumors was reflected in multiple levels and multiple pathways, providing reasonable evidence for new drug development. To make TCM and natural medicine widely and flexibly used in clinical practice, the efficacy, safety and mechanism of action need more in-depth experimental research.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Natural medicine; Signaling pathway; Target; Traditional Chinese medicine; Triple-negative breast cancer

Mesh:

Substances:

Year:  2020        PMID: 32810619     DOI: 10.1016/j.jep.2020.113249

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  23 in total

1.  Celastrol inhibits the migration and invasion and enhances the anti-cancer effects of docetaxel in human triple-negative breast cancer cells.

Authors:  Zi Liu; Minghui Fan; Xiaojing Xuan; Chenlu Xia; Guozheng Huang; Liang Ma
Journal:  Med Oncol       Date:  2022-09-07       Impact factor: 3.738

Review 2.  Signaling Pathways and Natural Compounds in Triple-Negative Breast Cancer Cell Line.

Authors:  Citra Dewi; Adryan Fristiohady; Riezki Amalia; Nur Kusaira Khairul Ikram; Sugeng Ibrahim; Muchtaridi Muchtaridi
Journal:  Molecules       Date:  2022-06-07       Impact factor: 4.927

3.  Exploration of the Effect and Potential Mechanism of Echinacoside Against Endometrial Cancer Based on Network Pharmacology and in vitro Experimental Verification.

Authors:  Wan Shu; Ziwei Wang; Rong Zhao; Rui Shi; Jun Zhang; Wei Zhang; Hongbo Wang
Journal:  Drug Des Devel Ther       Date:  2022-06-16       Impact factor: 4.319

Review 4.  Stem Cell Models for Cancer Therapy.

Authors:  Nitin Telang
Journal:  Int J Mol Sci       Date:  2022-06-24       Impact factor: 6.208

5.  The Yunnan national medicine Maytenus compound inhibits the proliferation of hepatocellular carcinoma (HCC) by suppressing the activation of the EGFR-PI3K-AKT signaling pathway.

Authors:  Wen-Tao Zhao; Liu-Xin Han; Lin Liu; Bao-Zhen Zeng; Yi Zhang; Liu-Fang Zhao; Hong-Yan Hu; Jia-Wei Xia; Yi-Ze Li; Xu-Dong Xiang; Xiao-Lin Lin; Di Lu; Gao-Feng Li
Journal:  J Cancer       Date:  2021-04-07       Impact factor: 4.207

6.  DNAJC12 as a Mediator Between ESR1 and ERBB4 in Breast Carcinoma Cells.

Authors:  Mianjie Lin; Ya-Nan Wang; Yixin Ye; Zhelei Xiong; Fengbiao Guo; Haibin Chen
Journal:  Front Oncol       Date:  2021-02-24       Impact factor: 6.244

7.  Astragalus membranaceus (Huangqi) and Rhizoma curcumae (Ezhu) decoction suppresses colorectal cancer via downregulation of Wnt5/β-Catenin signal.

Authors:  Yong Bian; Gang Wang; Jing Zhou; Gang Yin; Tiantian Liu; Li Liang; Xinyue Yang; Wen Zhang; Kexin Ni; Decai Tang; Yun Yu
Journal:  Chin Med       Date:  2022-01-06       Impact factor: 5.455

Review 8.  The Application of Citrus folium in Breast Cancer and the Mechanism of Its Main Component Nobiletin: A Systematic Review.

Authors:  Yuan Wu; Chien-Shan Cheng; Qiong Li; Jing-Xian Chen; Ling-Ling Lv; Jia-Yue Xu; Kai-Yuan Zhang; Lan Zheng
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-29       Impact factor: 2.629

Review 9.  Recent Advances in Anti-Metastatic Approaches of Herbal Medicines in 5 Major Cancers: From Traditional Medicine to Modern Drug Discovery.

Authors:  Jinkyung Park; Dahee Jeong; Meeryoung Song; Bonglee Kim
Journal:  Antioxidants (Basel)       Date:  2021-03-27

Review 10.  Growth Inhibitory Efficacy of Chinese Herbs in a Cellular Model for Triple-Negative Breast Cancer.

Authors:  Nitin T Telang; Hareesh B Nair; George Y C Wong
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.